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The effect of N-acetylcysteine on growth and biofilm formation
in Staphylococcus epidermidis strains
Sahra KIRMUSAOĞLU1, Seyhun YURDUGÜL1, M. Esra KOÇOĞLU2

Aim: To examine the possible preventive effect of N-acetylcysteine (NAC) on biofilm formation in Staphylococcus
epidermidis strains, which cause very important problems such as implant-associated infections in hospitalized and
immunocompromised patients worldwide.
Materials and methods: The effects of varying concentrations of NAC on the formation of biofilm by 28 strains of
Staphylococcus epidermidis was investigated spectrophotometrically by micro-ELISA assay.
Results: Significant differences in biofilm formation in the presence of various NAC concentrations were found in
15 methicillin-resistant Staphylococcus epidermidis and 13 methicillin-sensitive Staphylococcus epidermidis strains (P <
0.05).
Conclusion: It was found that slime formation was decreased due to the increased concentrations of the NAC treatments.
Based on these findings, it is possible to use NAC as an antibiofilm agent on medical devices or in catheter lock solutions
to prevent colonization and implant-associated infections.
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N-asetilsisteinin Staphylococcus epidermidis suşlarında üreme ve biyofilm oluşturma
üzerine etkisi
Amaç: Bu çalışmanın amacı N-asetilsisteinin (NAC) hastaneye yatmış ve bağışıklık sistemi baskılanmış hastalarda, tüm
dünyada implant ile ilişkili infeksiyonlar gibi çok önemli sorunlara neden olan Staphylococcus epidermidis suşlarında
biyofilm oluşumundaki olası önleyici etkilerini incelemekti.
Yöntem ve gereç: NAC’nin çeşitli konsantrasyonlarının 28 Staphylococcus epidermidis suşu tarafından oluşturulan
biyofilm üzerine etkisi mikroelisa yöntemiyle spektrofotometrik olarak test edildi.
Bulgular: NAC’nin çeşitli konsantrasyonlarının varlığında 15 metisilin dirençli Staphylococcus epidermidis ve 13
metisilin duyarlı Staphylococcus epidermidis suşlarında biyofilm oluşturma üzerinde anlamlı farklılıklar bulundu (P <
0,05).
Sonuç: NAC’nin artan konsantrasyonlarından dolayı yapışkan tabaka oluşumunda azalma görüldü. Bu bulgulara göre,
kolonizasyonu ve yabancı cisim infeksiyonlarını önlemek için NAC’ in medikal aletlerde ya da kateter solüsyonlarında
antibiyofilm ajan olarak kullanımı mümkündür.
Anahtar sözcükler: Staphylococcus epidermidis, biyofilm oluşumu, yabancı cisim infeksiyonları, N-asetilsistein
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Introduction
The placement of indwelling medical devices into the
human body for supporting and restoring function
has become common practice in medicine (1).
Indwelling device-associated infections demonstrate
serious complications of high significance with
related high morbidity and mortality rates, and also
with high associated healthcare costs (2).
S. epidermidis is one of the most frequent causes
of nosocomial infections (3) and the most common
source of infections of indwelling medical devices
such as intravascular catheters, cerebrospinal fluid
shunts, prosthetic heart valves, peritoneal dialysis
catheters, and prosthetic joints. S. epidermidis,
which is a colonizer of human skin, can cause
contamination of medical devices during insertion
(4). The biofilm is broadly protective against host
defenses (1). Infections of medical prosthetic devices
in trauma and orthopedic surgery, which are difficult
to treat with conventional therapies like antibiotics
and surgery (5), may lead to removal of the implant
to destroy biofilm-associated infections (6) and may
lead to removal of the implant with function loss of
the affected limb (7,8). The prevalence of methicillinresistant S. epidermidis (MRSE) strains (9-11) and the
emergence of vancomycin-resistant S. epidermidis
(VRSE) further complicate the treatment of medical
prosthetic device infections (12,13).
Antibiofilm activities of antibiotics or biocides
combined with biofilm-specific agents such as
N-acetylcysteine (NAC) (14), protamine sulfate (15),
and dispersin B (16), which primarily target the
extracellular matrix of biofilms, have been examined.
Many drugs and compounds have been tested as
biofilm inhibitors and some of these (e.g., silver,
minocycline, rifampin, platinum, nitrofurantoin,
chlorhexidine, and sulfadiazine) are used to coat
catheters (17-20).
NAC, which is a nonantibiotic drug, has
antibacterial properties. It is a mucolytic agent that
disrupts disulfide bonds in mucus and, for this reason,
it reduces the viscosity of secretions (21). In recent
years, the actions of NAC in clinical applications have
also broadened. NAC is widely used as a mucolytic
agent and in the treatment of HIV, and its efficacy
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in chronic obstructive pulmonary disease and
nephropathy has been reported (22). NAC, which
is a glutathione precursor, provides neuroprotection
by preventing oxidative damage (22,23). In addition,
NAC is also used in the treatment of chronic
bronchitis, cancer, and paracetamol intoxication
(24,25). Acetylcysteine has been used to treat
aspergilloma by local installation (26). NAC has
been found to reduce biofilm formation by a variety
of bacteria (21,27,28) and promote the disruption of
mature biofilm (27,28).
Materials and methods
Bacteria
Fifteen MRSE and 13 methicillin-sensitive S.
epidermidis (MSSE) isolates from samples from
patients who visited the microbiology laboratory
of Abant İzzet Baysal University Hospital (Faculty
of Medicine, Abant İzzet Baysal University, Bolu,
Turkey) were used as test microorganisms.
All of the isolates were identified as S. epidermidis
according to colonial and microscopic morphology,
positive catalase, and negative coagulase in the
laboratory. All of the isolates were tested for
methicillin resistance. The disk diffusion method was
used with a 1-μg oxacillin disk (Oxoid, Basingstoke,
UK). Isolates with zone sizes of ≤10 mm were
considered methicillin-resistant.
Treatment with NAC
NAC was added to tryptic soy broth (TSB) (Merck,
Whitehouse Station, NJ, USA) at concentrations of
0.03, 0.12, 0.5, and 2.0 mg/mL. Each concentration
of NAC was analyzed separately. Isolates were
inoculated into NAC-treated TSB and nontreated
TSB as a control, which were then incubated at 37 °C
for 24 h in the incubator. The process was repeated
in triplicate.
Qualitative determination of the slime
Congo red agar method
For screening biofilm formation by S. aureus, bacteria
were grown on Congo red agar (Merck) as described
by Freeman et al. (1989) (29). Colony morphology
was examined after holding at 37 °C for 24 h. A
positive result was indicated by black colonies.
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Tube method
The case study was verified by an assay, in which
the biofilm formation by bacteria was additionally
detected by another method described by Christensen
et al. (1985). S. epidermidis isolates were inoculated in
a polystyrene test tube that contained TSB and were
then incubated at 37 °C for 24 h in the incubator (30).
The biofilms that formed on the walls of the polystyrene
test tube were washed twice with phosphate buffered
saline (PBS) to remove the planktonic cells. The
cells were then stained with safranin for 1 h. After
discarding the safranin, the polystyrene test tube was
washed twice with PBS and the process of air-drying
the polystyrene test tube was conducted. If a visible
film had lined the walls of the tube, slime production
could be confirmed (30). The adherent bacterial films
were measured spectrophotometrically at 540 nm in
a microplate reader (Thermo Fisher, Waltham, MA,
USA). This process was repeated with NAC-treated
TSB at concentrations of 0.03, 0.12, 0.5, and 2.0 mg/
mL to determine the effects of the NAC on the slime
production of the isolates. The procedures were
repeated in triplicate.
Quantitative determination of the slime
Nontreated TSB was used for the control. TSB
supplemented with the different concentrations
of NAC was also used. The optical density (OD)
value of the inoculum was approximately 0.600 nm,
as calculated with a spectrophotometer (Hitachi,
Tokyo, Japan), and 200 μL of bacterial suspension
that contained TSB was inoculated into a 96-well flatbottomed sterile polystyrene microplate (LP Italiana,
Milan, Italy). Some wells were left free of NAC as
controls and the wells were incubated for 24 h at 37
°C.
The biofilm formation by bacteria was detected by
the method described by Christensen et al., as follows
(30). The biofilms that formed on the plates were
washed twice with PBS to remove the planktonic
cells. The cells were then stained with safranin
(EMD Chemicals Inc., Gibbstown, NJ, USA) for 1 h.
After removal of safranin from the microplate, the
microplate was washed twice with PBS, followed by
the air-drying of the wells. Adherent bacterial films
were measured spectrophotometrically at 540 nm in a
microplate reader (Thermo Fisher). This process was
repeated with NAC-treated TSB at concentrations

of 0.03, 0.12, 0.5, and 2.0 mg/mL to determine the
effects of NAC on the slime production of the isolates.
Determination of the slime index
Following the 24-h incubation of the isolates, which
were treated with different concentrations of NAC,
the growth of S. epidermidis was confirmed with a
micro-ELISA reader instrument (Thermo Fisher).
The OD value of the biofilm corresponded with
the OD value of the bacterial growth determined
spectrophotometrically, before the aspiration of
the culture, in order to compensate for the partial
inhibition in growth caused by the NAC, and this was
called the slime index (SI). The result was expressed
as a percentage relative to the control without NAC.
For this purpose, the following formula was applied:
SI = 100 × (mean density of biofilm with treatment
/ mean growth with treatment) / (mean density of
biofilm without treatment / mean growth without
treatment) (21).
Statistical analysis
The Friedman test was used to determine the existence
of differences in the different concentrations of NAC.
The comparison between the different concentrations
of NAC was carried out with the 2 related sample
tests (Wilcoxon test) where significant differences
were present. At the beginning of the study, P < 0.05
was set as statistically significant.
Results
In this study, 28 investigated strains of S. epidermidis
were found to be biofilm-producing. The results
determined by spectrophotometric assay for growth
and biofilm formation in the presence of different
concentrations of NAC are shown in Table 1.
It was found that there were significant differences
in biofilm formation and growth among the different
concentrations of NAC (P < 0.05). In addition, there
were significant differences in the biofilm formation of
MSSE and MRSE among the different concentrations
of NAC. The decrease in the OD of the biofilms was
probably in direct relation to the NAC concentration
(Table 1). NAC applied at 4 different concentrations
showed the same effect on the biofilm formation and
growth of MSSE and MRSE (P < 0.05).
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Table 1. Friedman test results showing the effects of different concentrations of NAC on the growth and biofilm formation of 28 isolates.
NAC (mean ± SD)

df

N

P

76.96 ± 3.88

3

28

0.019*

66.00 ± 2.11

56.47 ± 2.07

3

28

0.000*

88.24 ± 1.75

77.02 ± 2.05

3

28

0.000*

0.03 mg/mL

0.12 mg/mL

0.5 mg/mL

2.0 mg/mL

SI

84.22 ± 26.04

76.90 ± 22.41

72.00 ± 2.42

Slime

79.72 ± 21.50

73.65 ± 26.14

Growth

98.35 ± 26.83

95.57 ± 23.61

*P < 0.05

At 4 different concentrations of NAC, 28 strains
were found to decrease the biofilm formation, and
NAC diminished the biofilm formation by 44% at a
concentration of 2.0 mg/mL. The mean percentage
of biofilm of all of the strains relative to the control
at a concentration of 0.03, 0.12, 0.5, and 2.0 mg/mL
of NAC was 79.72 ± 21.50%, 73.65 ± 26.14%, 66.00
± 2.11%, and 56.47 ± 2.07% (P < 0.05), respectively
(Table 1). NAC demonstrated a dose-dependent
slime reducing activity at the 4 concentrations of
NAC (Tables 1 and 2).
The SI indicates that there is a significant difference
in biofilm formation between the concentrations of
0.03 and 0.5 mg/mL and between the concentrations
of 0.03 and 2.0 mg/mL (P < 0.05) (Table 2). Therefore,
the inhibitory effects of NAC on biofilm formation
are the same at the concentrations of both 0.5 and 2.0
mg/mL (P < 0.05) (Table 2), and are higher than the
inhibitory effect of the concentration of 0.03 mg/mL
(Table 1).
At 4 different concentrations, NAC decreased the
growth of 28 strains; this was found to be statistically
significant (Table 1). The inhibitory effects of NAC on

growth were the same at the concentrations of 0.03
and 0.12 mg/mL, and were less than the inhibitory
effects of the concentrations of 0.5 and 2.0 mg/mL
(Tables 1 and 2).
Discussion
The prevalence of MRSE strains (9-11) and the
emergence of vancomycin-resistance in these species
further complicate the treatment of biomaterial
infections (12,13). Nosocomial staphylococcal
foreign-body infections related to biofilm formation
are a serious threat, demanding new and effective
therapeutic and preventive strategies.
Several studies have been conducted to decrease
the adherence of several bacteria, such as coagulasenegative Staphylococcus, on catheters by coating them
with antiseptics and silver (18,20). The antibiofilm
activities of antibiotics combined with NAC (14),
protamine sulfate (15), and dispersin B (16) have
been examined in recent studies. NAC was found to
decrease biofilm formation by a variety of bacteria
(21,27,28) and to promote the disruption of mature
biofilm (27,28).

Table 2. Wilcoxon test results showing the effects of different concentrations of NAC on the growth and biofilm formation of 28 isolates.
Concentrations of NAC (mg/mL-mg/mL)
0.12-0.03

P

2.0-0.03

0.5-0.12

2.0-0.12

2.0-0.5

SI

0.076

0.011*

0.022*

0.200

0.203

0.615

Slime

0.000*

0.000*

0.000*

0.000*

0.000*

0.000*

Growth

0.295

0.002*

0.000*

0.018*

0.000*

0.002*

*P < 0.05
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In our study using 0.03, 0.12, 0.5, and 2.0 mg/
mL of NAC, 28 strains lost 20%, 26%, 34%, and
44% of their capacity to produce biofilms. Juda et
al. (19) studied the effect of EDTA on the formation
of biofilm by S. epidermidis and showed that the
adhesion and formation of the S. epidermidis biofilm
on polychloride vinyl Nelaton and Thorax catheters
was inhibited by EDTA at low concentrations
(between 1 and 2 mmol/L) (19).
Our results show that NAC decreases growthindependent formation of biofilm, which is a major
virulence factor of staphylococcal infections. For
this reason, NAC may be an effective alternative for
preventing indwelling prosthetic infections by S.
epidermidis. This study has demonstrated that higher
doses of NAC lead to lower levels of biofilm formation.
In the presence of NAC at concentrations of 0.03
mg/mL or higher, the results become statistically
significant. Four different concentrations of NAC
showed the same effect on the biofilm formation and
growth of MSSE and MRSE.
It would be appropriate to confirm these results
by animal and clinical experiments. NAC could
be administered through direct instillation, either
intravenously or orally. However, it may be possible
to obtain useful concentrations by local application
to prevent the formation of biofilms and adherence
of S. epidermidis. NAC may be incorporated into

indwelling devices to prevent the adhesion of S.
epidermidis on the devices. It is very difficult to
remove an infected device, and the necessity of this
may be prevented with the use of NAC. Indwelling
device-associated infections, even by MRSE, may
be prevented without using antibiotics or other
chemicals, which may cause the development of
resistance in bacteria.
In conclusion, our results suggest that NAC could
prevent the formation of biofilms and adherence of S.
epidermidis. NAC is a specific antibiofilm compound
and might be used as an antibiofilm coating on
medical devices or in catheter lock solution to
prevent colonization and infection by biofilm
pathogens. When incurable indwelling deviceassociated infections arise from S. epidermidis, NAC
could be an alternative treatment to antibiotics. In
this way, resistance to antibiotics in bacteria could be
decreased.
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